Literature DB >> 23991329

Refractory hypertension with massive proteinuria may be reversed in renal artery stenosis patients with low proteinuria selectivity index after stenting.

Bing Gu1, Qin Che, Weihao Li, Chuanwei Zhou, Di Xu, Junhong Wang, Yan Guo.   

Abstract

BACKGROUND: No available prognostic factor was identified for atherosclerotic renovascular stenosis (ARAS) patient who undergo the percutaneous revascularization therapy. REPORT: This is a case of 68-year-old ARAS patient associated with hypertension and massive proteinuria, who exhibited progressive aggravation of renal dysfunction. His proteinuria selectivity index (SI) was only 0.08. Then the stenosis was treated by percutaneous transluminal angioplasty of the renal artery (PTRA) and stenting. After 2-year follow up, all symptoms including renal dysfunction and uncontrolled hypertension was well-controlled. DISCUSSION: As no reliable predictors of clinical response have been identified yet, SI might be a simple prognositic index for ARAS patients undergone the revascularzation therapy.

Entities:  

Keywords:  Atherosclerotic renovascular stenosis (ARAS); Refractory hypertension; proteinuria; renal artery stenosis; revascularzation therapy; selectivity index (SI)

Year:  2013        PMID: 23991329      PMCID: PMC3755686          DOI: 10.3978/j.issn.2072-1439.2013.08.34

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  10 in total

1.  Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritis.

Authors:  Emily P McQuarrie; Loai Shakerdi; Alan G Jardine; Jonathan G Fox; Bruce Mackinnon
Journal:  Nephrol Dial Transplant       Date:  2010-10-04       Impact factor: 5.992

2.  Nephrotic range proteinuria associated with unilateral renal artery stenosis.

Authors:  Anuradha Wadhwa; Amir Kazory
Journal:  Int Urol Nephrol       Date:  2008-05-20       Impact factor: 2.370

3.  Relationship between clinical predictors and tubulointerstitial damage in adult-onset primary nephrotic syndrome.

Authors:  Fu You Liu; Ying Li; You Ming Peng; Li Yang; Shao Bin Duan; Jun Li; Xing Chen; Yun Cheng Xia; Ning Guo; Xiang Qing Xu
Journal:  Arch Med Res       Date:  2006-11       Impact factor: 2.235

4.  High proteinuria selectivity index based upon IgM is a strong predictor of poor renal survival in glomerular diseases.

Authors:  O Bakoush; O Torffvit; B Rippe; J Tencer
Journal:  Nephrol Dial Transplant       Date:  2001-07       Impact factor: 5.992

5.  Selective stenting and the course of atherosclerotic renovascular nephropathy.

Authors:  Andrea Campo; Roberto Boero; Piero Stratta; Francesco Quarello
Journal:  J Nephrol       Date:  2002 Sep-Oct       Impact factor: 3.902

6.  A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.

Authors:  C Bazzi; C Petrini; V Rizza; G Arrigo; G D'Amico
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

7.  Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients.

Authors:  Gerald Dorros; Michael Jaff; Lynne Mathiak; Thomas He
Journal:  Catheter Cardiovasc Interv       Date:  2002-02       Impact factor: 2.692

8.  Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials.

Authors:  Dharam J Kumbhani; Anthony A Bavry; James E Harvey; Russell de Souza; Roberto Scarpioni; Deepak L Bhatt; Samir R Kapadia
Journal:  Am Heart J       Date:  2011-03       Impact factor: 4.749

9.  Outcome after endovascular revascularization of atherosclerotic renal artery stenosis.

Authors:  H Eklöf; D Bergqvist; A Hägg; R Nyman
Journal:  Acta Radiol       Date:  2009-04       Impact factor: 1.990

10.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-03-21       Impact factor: 24.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.